Status:
RECRUITING
OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression
Lead Sponsor:
Hackensack Meridian Health
Collaborating Sponsors:
New Jersey Health Foundation
Conditions:
Post Partum Depression
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Postpartum Depression (PPD) is defined as depression that occurs after childbirth, with intense symptoms that last longer than "baby blues". PPD differs greatly from "baby blues", a term used to descr...
Eligibility Criteria
Inclusion
- Mother of NICU infant
- Older than age 18
- English-speaking
- Gave birth more than 24 hours ago and less than 12 months prior to enrollment
- Depression as assessed by:
- Current/Prior diagnosis of Major Depressive Disorder OR EPDS score above 10 OR EPDS score below 10 AND Endorsement of "sometimes" or "often" on item #10 on the EPDS\* ("I have had thoughts of harming myself")
Exclusion
- A diagnosis of Substance Dependency or Substance Use
- Acute suicidal or infanticidal ideation
- Current psychosis
- Medical history of cognitive impairment
- Infant death of current NICU admission
- Marked non-compliance with intervention (e.g, non-attendance of more than one session during a 4-week intervention or failure to complete study assessments),
- Are in medical treatment that would prevent participation (i.e., medical treatment that requires inpatient hospitalization and thus would prevent participation of study visits.)
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06991166
Start Date
September 15 2025
End Date
September 1 2027
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601